CLINPRO 5000- sodium fluoride paste, dentifrice

Clinpro 5000 by

Drug Labeling and Warnings

Clinpro 5000 by is a Prescription medication manufactured, distributed, or labeled by 3M ESPE Dental Products. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

  • 1 INDICATIONS AND USAGE

    Clinpro 5000 Anti-Cavity Toothpaste is indicated for use as part of a professional program for the prevention and control of dental caries.

  • 2 DOSAGE AND ADMINISTRATION

    Use once daily in place of conventional toothpaste unless instructed otherwise by a physician or dentist.

    Apply a thin ribbon or pea-sized amount of Clinpro 5000 Anti-Cavity Toothpaste using a soft-bristled toothbrush and brush teeth for at least two minutes.

    After brushing adults should expectorate. Children 6 to 16 years of age should expectorate and rinse mouth thoroughly with water.

    Follow these instructions or use as directed by a dental professional.

  • 3 DOSAGE FORMS AND STRENGTHS

    White toothpaste containing 1.1% sodium fluoride

  • 4 CONTRAINDICATIONS

    Do not use in children under 6 years of age unless recommended by a dentist or physician.

  • 5 WARNINGS AND PRECAUTIONS

    DO NOT SWALLOW. If more than a pea-sized amount of Clinpro 5000 Anti-Cavity Toothpaste is swallowed, contact a medical or dental professional or a poison control center.

    Keep out of reach of children under 6 years of age.

    Repeated ingestion of high levels of fluoride may cause dental fluorosis. For this reason, use in children with developing dentition requires special supervision to prevent swallowing. Prescribing dentists and physicians should consider risk of fluorosis when prescribing for use in children less than 6 years of age.

  • 6 ADVERSE REACTIONS

    Allergic reactions and other idiosyncrasies have been rarely reported.

  • 8 USE IN SPECIFIC POPULATIONS

    8.1 Pregnancy

    Fluoride crosses the placenta in women and has been measured in cord blood, amniotic fluid, and serum of newborn children, but without a consistent correlation to maternal serum fluoride levels.1,2 There are no data to indicate an increased susceptibility to fluorosis during pregnancy. Developmental studies were conducted by the National Toxicology Program, with sodium fluoride administered in the drinking water to pregnant rats and rabbits. No developmental toxicity was observed, even at doses that caused maternal toxicity. The No Adverse Effect Levels were about 29 mg/kg-day and 27 mg/kg-day for rabbits and rats, respectively.3 There is no conclusive evidence of fluoride developmental effects in humans.1,2

    The Institute of Medicine established a fluoride Upper Limit of 10 mg/day for pregnant women.2

    Prescribing physicians and dentists should consider total fluoride exposure (dental care plus food, water and other sources) when prescribing the product for use in pregnant women or women who may become pregnant.

    8.3 Nursing Mothers

    An extremely small proportion of fluoride in drinking water is transferred to breast milk. The Institute of Medicine established a fluoride Upper Limit of 10 mg/day for nursing women.2 Prescribing physicians and dentists should consider total fluoride exposure (dental care plus food, water and other sources) when prescribing the product for use in women who are nursing.

    8.4 Pediatric Use

    The primary adverse effects of fluoride are fluorosis of dental enamel and of the skeleton; these effects occur at exposures below those associated with other adverse health effects. The population most at risk for dental fluorosis is children during the period of tooth formation, i.e. from birth to 8 years of age. For this population, the Institute of Medicine established Fluoride Upper Limits of intake based on the risk of dental fluorosis. In populations with permanent dentition, skeletal fluorosis is the greatest risk from excessive fluoride. For this population the Institute of Medicine (IOM) established Fluoride Upper Limits based on the risk of skeletal fluorosis.2

    Population IOM Fluoride Upper Limit
    Infants 0-6 months old 0.7 mg/day
    Infants 7-12 months old 0.9 mg/day
    Children 1-3 years old 1.3 mg/day
    Children 4-8 years old 2.2 mg/day
    Children > 8 years old 10 mg/day

    Prescribing physicians and dentists should consider total fluoride exposure (dental care plus food, water and other sources) when prescribing the product for use in children.

    8.5 Geriatric Use

    No studies of Clinpro 5000 Anti-Cavity Toothpaste have been conducted to determine whether subjects aged 65 and over respond differently from younger subjects.

  • 10 OVERDOSAGE

    Ingestion of large amounts of fluoride may result in abdominal pain, stomach upset, nausea, vomiting, and diarrhea. These symptoms may occur at overdosages of 5 mg/kg of body weight. Fluoride doses of 16 mg/kg have been fatal.

    Treatment Recommendations for Overdose of Clinpro 5000 Anti-Cavity Toothpaste4
    Ingested fluoride dose Amount for 10 kg (22 pound) child* Recommended action to take
    Less than 5 mg/kg This equals less than ½ ounce (or less than 3 teaspoons). Do not induce vomiting. Give 1-2 glasses of milk and observe for symptoms of stomach upset. If symptoms persist more than a few hours, seek medical attention or contact a poison control center.
    5 mg/kg or more This equals about ½ ounce (about 1 tablespoon) or more. Do not induce vomiting. Give 1-2 glasses of milk and seek medical attention or contact a poison control center.
    15 mg/kg This equals 1 ounce or ¼ of the tube. Seek immediate medical attention. Do not induce vomiting. Give 1-2 glasses of milk.
    *The amount to reach the fluoride dose will be proportionately larger with older children and adults.

    A thin ribbon or pea-sized amount of Clinpro 5000 Anti-Cavity Toothpaste weighs approximately 0.3 g and contains approximately 1.5 mg of fluoride ion. A 4 oz. tube contains 564 mg of fluoride ion.
  • 11 DESCRIPTION

    Clinpro 5000 1.1% Sodium Fluoride Anti-Cavity Toothpaste is a self-applied fluoride dentifrice for the prevention of dental caries. Each gram contains 5 mg of fluoride ion in a neutral pH base, consisting of water, sorbitol, hydrated silica, glycerin, polyethylene-polypropylene glycol, flavor, polyethylene glycol, sodium lauryl sulfate, titanium dioxide, carboxymethyl cellulose, sodium saccharin and tri-calcium phosphate.

  • 12 CLINICAL PHARMACOLOGY

    Clinpro 5000 1.1% Sodium Fluoride Anti-Cavity Toothpaste aids in the prevention of tooth decay. Fluoride delivered from Clinpro 5000 inhibits the demineralization of sound teeth and enhances the remineralization (i.e., repair) of demineralized teeth. During tooth brushing, fluoride is taken up by teeth and dental plaque. Fluoride is taken up with calcium and phosphate by demineralized teeth resulting in an improved tooth structure than contains more fluoride and less carbonate than naturally occurring tooth structure and is more resistant to acid challenge. Additionally, calcium fluoride is formed on the crystal structure of teeth. As the pH of the mouth drops, fluoride is released from calcium fluoride and aids in the remineralization of teeth. Fluoride taken up into plaque alters the activity of cariogenic bacteria. Fluoride inhibits the process by which cariogenic bacteria metabolize carbohydrates resulting in less acid and adhesive polysaccharide production by the bacteria.

  • 15 REFERENCES

    1. National Research Council. Fluoride in drinking water: A scientific review of EPA's standards; National Academies Press 2006.
    2. IOM. Dietary Reference Intakes: The essential guide to nutrient requirements. National Academies Press 2006.
    3. Heindel JJ, et al. Developmental toxicity evaluation of sodium fluoride administered to rats and rabbits in drinking water. Fundam Appl Toxicol 1996;30(2):162-177.
    4. Poisindex. Toxicologic Management – Fluoride. Thomson Micromedex.
  • 16 HOW SUPPLIED/STORAGE AND HANDLING

    Clinpro 5000 Anti-Cavity Toothpaste is supplied as a white dentifrice paste in a 4 oz. (113 gm) plastic tube (NDC: 48878-3120-4, Vanilla Mint Flavor; NDC: 48878-3130-4 Spearmint Flavor; NDC: 48878-3140-4 Bubble Gum Flavor).

    Storage

    This product is designed to be stored and used at room temperature. Do not freeze or expose to extreme heat. See outer package for expiration date.

    Manufactured for:
    3M ESPE
    Dental Products
    2510 Conway Avenue
    St. Paul, MN 55144-1000 USA
    Revision date: 01/11/2012

    Rx Only

    3M, ESPE, and Clinpro are trademarks of 3M or 3M Deutschland GmbH.
    © 3M 2016. All rights reserved.

  • PRINCIPAL DISPLAY PANEL

    Principal Display Panel – Box Label

    3M ESPE

    NDC: 48878-3120-4

    Clinpro™ 5000

    Vanilla Mint

    1.1% Sodium Fluoride

    Anti-Cavity Toothpaste

    Innovative

    Tri-Calcium

    Phosphate

    Exclusively from 3M ESPE

    Contents: 1 Tube NET WT 4oz (113g)

    Rx Only

    Principal Display Panel – Box Label
  • PRINCIPAL DISPLAY PANEL

    Principal Display Panel – Box Label

    3M ESPE

    NDC: 48878-3130-4

    Clinpro™ 5000

    Spearmint

    1.1% Sodium Fluoride

    Anti-Cavity Toothpaste

    Innovative

    Tri-Calcium

    Phosphate

    Exclusively from 3M ESPE

    Contents: 1 Tube NET WT 4oz (113g)

    Rx Only

    Principal Display Panel – Box Label

  • PRINCIPAL DISPLAY PANEL

    Principal Display Panel – Box Label

    3M ESPE

    NDC: 48878-3140-4

    Clinpro™ 5000

    Bubble Gum

    1.1% Sodium Fluoride

    Anti-Cavity Toothpaste

    Innovative

    Tri-Calcium

    Phosphate

    Exclusively from 3M ESPE

    Contents: 1 Tube NET WT 4oz (113g)

    Rx Only

    Principal Display Panel – Box Label
  • INGREDIENTS AND APPEARANCE
    CLINPRO 5000 
    sodium fluoride paste, dentifrice
    Product Information
    Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC: 48878-3120
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    sodium fluoride (UNII: 8ZYQ1474W7) (fluoride ion - UNII:Q80VPU408O) fluoride ion5 mg  in 1 g
    Inactive Ingredients
    Ingredient NameStrength
    water (UNII: 059QF0KO0R)  
    sorbitol (UNII: 506T60A25R)  
    silicon dioxide (UNII: ETJ7Z6XBU4)  
    glycerin (UNII: PDC6A3C0OX)  
    POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  
    sodium lauryl sulfate (UNII: 368GB5141J)  
    titanium dioxide (UNII: 15FIX9V2JP)  
    carboxymethylcellulose sodium (UNII: K679OBS311)  
    saccharin sodium (UNII: SB8ZUX40TY)  
    tricalcium phosphate (UNII: K4C08XP666)  
    Product Characteristics
    Color    Score    
    ShapeSize
    FlavorMINT (MINT) Imprint Code
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC: 48878-3120-41 in 1 BOX01/01/2009
    1113 g in 1 TUBE; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    unapproved drug other01/01/2009
    CLINPRO 5000 
    sodium fluoride paste, dentifrice
    Product Information
    Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC: 48878-3130
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    sodium fluoride (UNII: 8ZYQ1474W7) (fluoride ion - UNII:Q80VPU408O) fluoride ion5 mg  in 1 g
    Inactive Ingredients
    Ingredient NameStrength
    water (UNII: 059QF0KO0R)  
    sorbitol (UNII: 506T60A25R)  
    silicon dioxide (UNII: ETJ7Z6XBU4)  
    glycerin (UNII: PDC6A3C0OX)  
    POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  
    sodium lauryl sulfate (UNII: 368GB5141J)  
    titanium dioxide (UNII: 15FIX9V2JP)  
    carboxymethylcellulose sodium (UNII: K679OBS311)  
    saccharin sodium (UNII: SB8ZUX40TY)  
    tricalcium phosphate (UNII: K4C08XP666)  
    Product Characteristics
    Color    Score    
    ShapeSize
    FlavorSPEARMINT (SPEARMINT) Imprint Code
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC: 48878-3130-41 in 1 BOX10/15/2010
    1113 g in 1 TUBE; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    unapproved drug other10/15/2010
    CLINPRO 5000 
    sodium fluoride paste, dentifrice
    Product Information
    Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC: 48878-3140
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    sodium fluoride (UNII: 8ZYQ1474W7) (fluoride ion - UNII:Q80VPU408O) fluoride ion5 mg  in 1 g
    Inactive Ingredients
    Ingredient NameStrength
    water (UNII: 059QF0KO0R)  
    sorbitol (UNII: 506T60A25R)  
    silicon dioxide (UNII: ETJ7Z6XBU4)  
    glycerin (UNII: PDC6A3C0OX)  
    POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  
    sodium lauryl sulfate (UNII: 368GB5141J)  
    titanium dioxide (UNII: 15FIX9V2JP)  
    carboxymethylcellulose sodium (UNII: K679OBS311)  
    saccharin sodium (UNII: SB8ZUX40TY)  
    tricalcium phosphate (UNII: K4C08XP666)  
    Product Characteristics
    Color    Score    
    ShapeSize
    FlavorBUBBLE GUM (BUBBLE GUM) Imprint Code
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC: 48878-3140-41 in 1 BOX01/07/2011
    1113 g in 1 TUBE; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    unapproved drug other01/07/2011
    Labeler - 3M ESPE Dental Products (801390852)

  • © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.